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18-month period of data collection were enrolled in the study. Of an initial group of 231 potentially eligible patients, 55 did not consent. Of these, 33 did not give any explanation, 7 patients felt they were not well enough, 2 feared the possible weight gain due to supplements, 5 did not want additional blood tests, 2 did not like sweet drinks, and one patient was unable to participate because English was not their first language. Therefore, a final group of 181 patients was included in the analysis. There were 84 patients in the intervention group and 97 patients in the control group. The patients in the intervention group had a mean age of 71.3 years (age range: 48 -88) and 67.9% were female. The patients in the control group had a mean age of 72.9 years (age range: 37 -90) and 62.9% were female. Food intake was analysed in a sub-group of patients who were randomly identified. This sub-group comprised 20 patients from the intervention group and 28 patients from the control group.
Study design
This was a prospective cohort study that was carried out in two wards of the North Tyneside General Hospital in Sheffield, UK. The patients were allocated to the control or intervention group according to the ward to which they were admitted. A crossover design was employed to remove any potential bias caused by differences in nursing staff. A single observer measured all clinical end points. The patients appear to have been followed until they were discharged from the hospital. No patient appears to have been lost to the follow-up assessment, although some outcomes were available only for the sub-groups of patients.
Analysis of effectiveness
All of the patients included in the initial study sample were accounted for in the effectiveness study. The primary outcome measures were: compliance rates; food intake analysis (energy intake and protein intake) in the sub-group of patients; major complications (wound infections, significant anaemia, pressure sores, bone fusion failure, pneumonia, deep vein thrombosis, pulmonary embolus and septicaemia); minor complications (urinary tract infections, transient cough or breathlessness, phlebitis, pressure area erythema, and transient pyrexia with no established diagnosis); any changes in medication, additional treatments (e.g. transfusions), specialised radiological investigations, and the number and type of biochemical and haematological assays; nutritional parameters (change in body mass index, grip strength and mid-arm-muscle circumference); and biochemical parameters (haemoglobin, C reactive protein, transferrin and albumin).
The two groups were comparable in terms of their demographics, clinical characteristics, and the type and frequency of orthopaedic surgery. The authors also stated that the sample of patients was representative of the whole orthopaedic inpatient population.
Effectiveness results
One hundred per cent compliance (taking the full intended number of supplements for the duration of the patient's hospital stay) was achieved in 14.9% of the patients.
The supplements were taken for a median of 4 days (range: 1 -55) and the median number of supplements taken was 4 (range: 0 -79).
Twenty per cent of patients were unable to comply at any level, but were included in the outcome analysis.
Almost 40% of the patients discontinued supplements at some point during the hospital admission. A similar 40% of
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In the sub-group analysis (20 patients in the supplemented group and 28 in the control group), the median energy intake was 1,527 kcal/day in the intervention group and 1,289 kcal/day in the control group, (p=0.02). No statistically significant differences were observed for median protein intake. The analysis revealed that those patients in the intervention group who did not receive any supplement had significantly lower energy intake than those who received full supplements.
The total number of major complications was 22 in the intervention group and 55 in the control group, (p=0.0002).
The most frequent complication was wound and joint infections (13.1% in the supplemented group and 21.6% in the control group). However, 11 of 14 patients in the supplemented group who developed major complications had taken less than five supplements in total.
The proportion of patients who developed major complications was 16.6% in the intervention group versus 35.1% in the control group, (p=0.005).
The rate of complications among planned admissions was 19% in the intervention group versus 28% in the control group, (p=0.273).
The rate of complications among emergency admissions was 9.5% in the intervention group versus 51% in the control group, (p=0.0016).
The difference in minor complications was not statistically significant.
Fewer additional treatments were required among the intervention patients. Only differences in the number of ultrasound scans (3 versus 12), antibiotics (35 versus 88 days), urea and electrolyte requests, and units of whole blood (41 versus 77) were statistically significant.
The median length of stay was 9 days (range: 7 -101) in the intervention group and 10 days (range: 7 -49) in the control group. The difference was not statistically significant.
The difference in nutritional parameters from baseline to 1-week post-admission did not reach statistical significance.
Among biochemical parameters, only the changes in mean haemoglobin (from 11.7 to 10.9 g/dL in the intervention group and from 12 to 10.9 g/dL in the control group) and transferrin (from 27.7 to 26.3 microg/L in the intervention group and from 28.8 to 26.5 microg/L in the control group) reached statistical significance.
Clinical conclusions
The effectiveness analysis showed that patients in the supplemented group achieved a significantly greater mean energy intake than patients in the non-supplemented group. Other clinical end points (in particular, the reduction in major complications) favoured the routine use of nutritional supplements.
Measure of benefits used in the economic analysis
The health outcomes were left disaggregated and no summary benefit measure was used in the economic analysis. In effect, a cost-consequences analysis was carried out.
Direct costs
Discounting was not relevant since the costs were incurred during a short timeframe. The unit costs were not reported, but the quantities of resources used were. The health services included in the economic evaluation were inpatient days and all additional treatments required in both groups. Surgery costs were not considered because they were comparable between groups. The cost/resource boundary of the study was not explicitly stated, but it could have been that of the hospital. Resource use was estimated using patient-level data that were derived from the sample of patients included in
